Plasma tRNA-derived small RNAs signature as a predictive and prognostic biomarker in lung adenocarcinoma

Abstract Background The prevalence of lung adenocarcinoma (LUAD) has increased, thus novel biomarkers for its early diagnosis is becoming more important than ever. tRNA-derived small RNA (tsRNA) is a new class of non-coding RNA which has important regulatory roles in cancer biology. This study was d...

Full description

Bibliographic Details
Main Authors: Jun Wang, Xianyu Liu, Weifang Cui, Qun Xie, Wei Peng, Heng Zhang, Yang Gao, Chunfang Zhang, Chaojun Duan
Format: Article
Language:English
Published: BMC 2022-02-01
Series:Cancer Cell International
Subjects:
Online Access:https://doi.org/10.1186/s12935-022-02481-6
_version_ 1818887647341314048
author Jun Wang
Xianyu Liu
Weifang Cui
Qun Xie
Wei Peng
Heng Zhang
Yang Gao
Chunfang Zhang
Chaojun Duan
author_facet Jun Wang
Xianyu Liu
Weifang Cui
Qun Xie
Wei Peng
Heng Zhang
Yang Gao
Chunfang Zhang
Chaojun Duan
author_sort Jun Wang
collection DOAJ
description Abstract Background The prevalence of lung adenocarcinoma (LUAD) has increased, thus novel biomarkers for its early diagnosis is becoming more important than ever. tRNA-derived small RNA (tsRNA) is a new class of non-coding RNA which has important regulatory roles in cancer biology. This study was designed to identify novel predictive and prognostic tsRNA biomarkers. Methods tsRNAs were identified and performed differential expression analysis from 10 plasma samples (6 LUAD and 4 normal, SRP266333) and 96 tissue samples (48 LUAD and 48 normal, SRP133217). Then a tsRNA-mRNA regulatory network was constructed to find hub tsRNAs. Functional enrichment analysis was performed to infer the potential pathways associated with tsRNAs. Afterwards, a Support Vector Machine (SVM) algorithm was used to explore the potential biomarkers for diagnosing LUAD. Lastly, the function of tRF-21-RK9P4P9L0 was explored in A549 and H1299 cell lines. Results A significant difference of read distribution was observed between normal people and LUAD patients whether in plasma or tissue. A tsRNA-mRNA regulatory network consisting of 155 DEtsRNAs (differential expression tsRNAs) and 406 DEmRNAs (differential expression mRNAs) was established. Three tsRNAs (tRF-16-L85J3KE, tRF-21-RK9P4P9L0 and tRF-16-PSQP4PE) were identified as hub genes with degree > 100. We found Co-DEmRNAs (intersection of DEtsRNAs target mRNAs and differentially expressed mRNAs in LUAD) were engaged in a number of cancer pathways. The AUC of the three hub tsRNAs’ expression for diagnosing LUAD reached 0.92. Furthermore, the qPCR validation of the three hub tsRNAs in 37 paired normal and LUAD tissues was consistent with the RNA-Seq results. In addition, tRF-21-RK9P4P9L0 was negatively associated with LUAD prognosis. Inhibition of tRF-21-RK9P4P9L0 expression reduced the proliferation, migration and invasion ability of A549 and H1299 cell lines. Conclusion These findings will help us further understand the molecular mechanisms of LUAD and contribute to novel diagnostic biomarkers and therapeutic target discovery.
first_indexed 2024-12-19T16:40:33Z
format Article
id doaj.art-b0aa8d65e9fe4214b5246dab7566bdfc
institution Directory Open Access Journal
issn 1475-2867
language English
last_indexed 2024-12-19T16:40:33Z
publishDate 2022-02-01
publisher BMC
record_format Article
series Cancer Cell International
spelling doaj.art-b0aa8d65e9fe4214b5246dab7566bdfc2022-12-21T20:13:48ZengBMCCancer Cell International1475-28672022-02-0122111510.1186/s12935-022-02481-6Plasma tRNA-derived small RNAs signature as a predictive and prognostic biomarker in lung adenocarcinomaJun Wang0Xianyu Liu1Weifang Cui2Qun Xie3Wei Peng4Heng Zhang5Yang Gao6Chunfang Zhang7Chaojun Duan8Department of Thoracic Surgery, Xiangya Hospital, Central South UniversityDepartment of Thoracic Surgery, Xiangya Hospital, Central South UniversityDepartment of Thoracic Surgery, Xiangya Hospital, Central South UniversityDepartment of Ultrasonic Imaging, Affiliated Hospital of Hunan Traditional Chinese Medicine Research InstituteDepartment of Oncology, Hunan Provincial People’s Hospital, the First Affiliated Hospital of Hunan Normal UniversityDepartment of Thoracic Surgery, Xiangya Hospital, Central South UniversityDepartment of Thoracic Surgery, Xiangya Hospital, Central South UniversityDepartment of Thoracic Surgery, Xiangya Hospital, Central South UniversityDepartment of Thoracic Surgery, Xiangya Hospital, Central South UniversityAbstract Background The prevalence of lung adenocarcinoma (LUAD) has increased, thus novel biomarkers for its early diagnosis is becoming more important than ever. tRNA-derived small RNA (tsRNA) is a new class of non-coding RNA which has important regulatory roles in cancer biology. This study was designed to identify novel predictive and prognostic tsRNA biomarkers. Methods tsRNAs were identified and performed differential expression analysis from 10 plasma samples (6 LUAD and 4 normal, SRP266333) and 96 tissue samples (48 LUAD and 48 normal, SRP133217). Then a tsRNA-mRNA regulatory network was constructed to find hub tsRNAs. Functional enrichment analysis was performed to infer the potential pathways associated with tsRNAs. Afterwards, a Support Vector Machine (SVM) algorithm was used to explore the potential biomarkers for diagnosing LUAD. Lastly, the function of tRF-21-RK9P4P9L0 was explored in A549 and H1299 cell lines. Results A significant difference of read distribution was observed between normal people and LUAD patients whether in plasma or tissue. A tsRNA-mRNA regulatory network consisting of 155 DEtsRNAs (differential expression tsRNAs) and 406 DEmRNAs (differential expression mRNAs) was established. Three tsRNAs (tRF-16-L85J3KE, tRF-21-RK9P4P9L0 and tRF-16-PSQP4PE) were identified as hub genes with degree > 100. We found Co-DEmRNAs (intersection of DEtsRNAs target mRNAs and differentially expressed mRNAs in LUAD) were engaged in a number of cancer pathways. The AUC of the three hub tsRNAs’ expression for diagnosing LUAD reached 0.92. Furthermore, the qPCR validation of the three hub tsRNAs in 37 paired normal and LUAD tissues was consistent with the RNA-Seq results. In addition, tRF-21-RK9P4P9L0 was negatively associated with LUAD prognosis. Inhibition of tRF-21-RK9P4P9L0 expression reduced the proliferation, migration and invasion ability of A549 and H1299 cell lines. Conclusion These findings will help us further understand the molecular mechanisms of LUAD and contribute to novel diagnostic biomarkers and therapeutic target discovery.https://doi.org/10.1186/s12935-022-02481-6Lung adenocarcinomatsRNAstRFsNetworkDiagnostic biomarker
spellingShingle Jun Wang
Xianyu Liu
Weifang Cui
Qun Xie
Wei Peng
Heng Zhang
Yang Gao
Chunfang Zhang
Chaojun Duan
Plasma tRNA-derived small RNAs signature as a predictive and prognostic biomarker in lung adenocarcinoma
Cancer Cell International
Lung adenocarcinoma
tsRNAs
tRFs
Network
Diagnostic biomarker
title Plasma tRNA-derived small RNAs signature as a predictive and prognostic biomarker in lung adenocarcinoma
title_full Plasma tRNA-derived small RNAs signature as a predictive and prognostic biomarker in lung adenocarcinoma
title_fullStr Plasma tRNA-derived small RNAs signature as a predictive and prognostic biomarker in lung adenocarcinoma
title_full_unstemmed Plasma tRNA-derived small RNAs signature as a predictive and prognostic biomarker in lung adenocarcinoma
title_short Plasma tRNA-derived small RNAs signature as a predictive and prognostic biomarker in lung adenocarcinoma
title_sort plasma trna derived small rnas signature as a predictive and prognostic biomarker in lung adenocarcinoma
topic Lung adenocarcinoma
tsRNAs
tRFs
Network
Diagnostic biomarker
url https://doi.org/10.1186/s12935-022-02481-6
work_keys_str_mv AT junwang plasmatrnaderivedsmallrnassignatureasapredictiveandprognosticbiomarkerinlungadenocarcinoma
AT xianyuliu plasmatrnaderivedsmallrnassignatureasapredictiveandprognosticbiomarkerinlungadenocarcinoma
AT weifangcui plasmatrnaderivedsmallrnassignatureasapredictiveandprognosticbiomarkerinlungadenocarcinoma
AT qunxie plasmatrnaderivedsmallrnassignatureasapredictiveandprognosticbiomarkerinlungadenocarcinoma
AT weipeng plasmatrnaderivedsmallrnassignatureasapredictiveandprognosticbiomarkerinlungadenocarcinoma
AT hengzhang plasmatrnaderivedsmallrnassignatureasapredictiveandprognosticbiomarkerinlungadenocarcinoma
AT yanggao plasmatrnaderivedsmallrnassignatureasapredictiveandprognosticbiomarkerinlungadenocarcinoma
AT chunfangzhang plasmatrnaderivedsmallrnassignatureasapredictiveandprognosticbiomarkerinlungadenocarcinoma
AT chaojunduan plasmatrnaderivedsmallrnassignatureasapredictiveandprognosticbiomarkerinlungadenocarcinoma